Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

The stage of diagnosis can impact survival rates. Patients with stage III multiple myeloma (MM) have an average life expectancy of 29 months, whereas patients with stages I and II disease survive on ...

Five FDA authorizations from Aug 2023–Apr 2024 expanded relapsed/refractory options, including bispecific/T-cell engager approaches, stem-cell mobilization, and two CAR T-cell products. Outcomes in ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Joseph Mikhael, MD ...